GDMC Charts a New Course in Genetic Therapy Innovation with Strategic Series A Investment

In an interview with BioPharma BoardRoom, Eric Blair, GDMC’s Chief Business Officer, discusses the company's strategic use of Series A funding to pio...

February 14, 2024 | Wednesday | Interview
Biotage AB Initiates Leadership Transition for Next Growth Phase

  From The BioPharma BoardRoom Lens   The news of Tomas Blomquist stepping down from his role as CEO & President of Biotage AB carries sev...

January 09, 2024 | Tuesday | Analysis
Setting Sail in 2024: BioPharma Boardroom's Strategic Compass

As we stand on the precipice of 2024, the life sciences industry continues its dynamic evolution, propelled by groundbreaking discoveries, technological ad...

January 01, 2024 | Monday | News
These worms have rhythm

Cold Spring Harbor Laboratory (CSHL) Professor Christopher Hammell has found that in the worm C. elegans, this genetic orchestra has no single conduct...

December 28, 2023 | Thursday | News
UK falls to third place in global Health Inclusivity Index

More than three in five (63%) people in the UK experience barriers to health inclusion People in UK, Canada and France face the longest waiting times to...

November 21, 2023 | Tuesday | Reports
Basel's Biotech Renaissance: Pioneering Gene Therapy and Beyond

In the world of biotechnology and pharmaceuticals, innovation is the lifeblood of progress. And in the picturesque Basel area, this spirit of innovation is...

September 25, 2023 | Monday | Reports
MoleculeAI's Quest: Revolutionizing Drug Discovery with Artificial Intelligence

In a rapidly evolving world where scientific breakthroughs are essential for the betterment of healthcare, MoleculeAI stands at the forefront, pioneering t...

September 11, 2023 | Monday | Interaction
Bayer President, Sebastian Guth, Highlights Alarming Link: Rising Fear, Lack of Education, and Distrust Hinder Access to Vital Preventative Care

One in Four American Adults Would Rather Not Know They Have Cancer   A new study from The Harris Poll, commissioned by Bayer, suggests fear factors ...

August 22, 2023 | Tuesday | Analysis
Study Finds Benefits of Telephone Cognitive Behavioural Therapy for Bariatric Surgery Patients

New research looking at the mental health and eating behaviours of patients 1-year after bariatric surgery has found that a short, 7-session telephone cogn...

August 04, 2023 | Friday | News
Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals

“Agilent is committed to our customers’ success at every stage of their journey to bring great science to life,” said Agilent President a...

August 01, 2023 | Tuesday | Reports
Promising At-Home Testing for Sexually Transmitted Infections Revealed in New Research

Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research pre...

July 31, 2023 | Monday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
Radioligand Binding Assays: From Opiate Receptors to Drug Discovery Mainstay

Using radioactive ligand binding methods, Dr. Snyder’s team found that the receptors were highly concentrated in areas of the brain involved in the s...

July 04, 2023 | Tuesday | Analysis
TLX250-CDx Shows Potential Utility in ccRCC Staging: New ZIRCON Phase III Data Presented in Australia.

New data demonstrates the ability of TLX250-CDx to detect extrarenal lesions, supporting potential clinical utility in the metastatic or recurrent setting,...

June 27, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close